pacritinib,momelotinib
gsk,cti biopharma
['mpnsm', '#mpn', 'momelotinib', 'pacritinib']
#eha2023 | poster | shares safety and anemia outcomes of momelotinib vs pacritinib in mf. momelotinib resulted in a more favorable safety profile, with fewer grade 3/4 aes and improved anemia outcomes. #mpn #mpnsm 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm